HTL-1071

AstraZeneca plc (ADR) Strikes 2 Immuno-Oncology Deals; Are Its Efforts In The Right Direction?
Bidness, ETC
Fri, 08/7/15 - 10:56 am
immuno-oncology
AstraZeneca
HTL-1071
Heptares Therapeutics
Mirati Therapeutics
MedImmune